From the Department of Urology (MAF, MPS, FCB), Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital (LML, PYW) and Department for Biomedical Research, University of Bern, Bern, Switzerland (MPS, FCB).
Eur J Anaesthesiol. 2018 Sep;35(9):641-649. doi: 10.1097/EJA.0000000000000808.
The use of noradrenaline to enable a restrictive approach to intra-operative fluid therapy to avoid salt and water overload has gained increasing acceptance. However, concerns have been raised about the impact of this approach on renal function.
To identify risk factors for acute kidney injury (AKI) in patients undergoing cystectomy with urinary diversion and determine whether administration of noradrenaline and intra-operative hydration regimens affect early postoperative renal function.
Retrospective observational cohort study.
University hospital, from 2007 to 2016.
A total of 769 consecutive patients scheduled for cystectomy and urinary diversion. Those with incomplete data and having pre-operative haemodialysis were excluded.
AKI was defined as a serum creatinine increase of more than 50% over 72 postoperative hours. Multiple logistic regression analysis was performed to model the association between risk factors and AKI.
Postoperative AKI was diagnosed in 86/769 patients (11.1%). Independent predictors for AKI were the amount of crystalloid administered (odds ratio (OR) 0.79 [95% confidence interval (CI), 0.68 to 0.91], P = 0.002), antihypertensive medication (OR 2.07 [95% CI, 1.25 to 3.43], P = 0.005), pre-operative haemoglobin value (OR 1.02 [95% CI, 1.01 to 1.03], P = 0.010), duration of surgery (OR 1.01 [95% CI, 1.00 to 1.01], P = 0.002), age (OR 1.32 [95% CI, 1.44 to 1.79], P = 0.002) but not the administration of noradrenaline (OR 1.09 [95% CI, 0.94 to 1.21], P = 0.097). Postoperative AKI was associated with longer hospital stay (18 [15 to 22] vs. 16 [15 to 19] days; P = 0.035) and a higher 90-day major postoperative complication rate (41.9 vs. 27.5%; P = 0.002).
Noradrenaline administration did not increase the risk for AKI. A too restrictive approach to administration of crystalloids was associated with an increased risk for AKI, particularly in older patients, those receiving antihypertensive medication, and those whose surgery was prolonged. As AKI was associated with longer hospital stay and increased postoperative morbidity, these observations should be taken into account to improve outcome when addressing peri-operative fluid management.
Not applicable.
去甲肾上腺素的使用使术中液体治疗限制策略成为可能,从而避免盐和水超负荷,但人们对这种方法对肾功能的影响表示担忧。
确定接受膀胱切除术和尿流改道术的患者发生急性肾损伤(AKI)的危险因素,并确定去甲肾上腺素的给药和术中补液方案是否会影响术后早期肾功能。
回顾性观察队列研究。
大学医院,2007 年至 2016 年。
共纳入 769 例计划接受膀胱切除术和尿流改道术的连续患者。排除数据不完整和术前接受血液透析的患者。
AKI 定义为术后 72 小时内血清肌酐升高超过 50%。采用多因素逻辑回归分析模型来分析危险因素与 AKI 之间的关系。
769 例患者中术后 AKI 诊断 86 例(11.1%)。AKI 的独立预测因素为晶体液输注量(比值比(OR)0.79 [95%置信区间(CI),0.68 至 0.91],P=0.002)、降压药物(OR 2.07 [95% CI,1.25 至 3.43],P=0.005)、术前血红蛋白值(OR 1.02 [95% CI,1.01 至 1.03],P=0.010)、手术持续时间(OR 1.01 [95% CI,1.00 至 1.01],P=0.002)、年龄(OR 1.32 [95% CI,1.44 至 1.79],P=0.002),但与去甲肾上腺素的给药无关(OR 1.09 [95% CI,0.94 至 1.21],P=0.097)。术后 AKI 与住院时间延长(18 [15 至 22]天 vs. 16 [15 至 19]天;P=0.035)和 90 天主要术后并发症发生率较高(41.9% vs. 27.5%;P=0.002)相关。
去甲肾上腺素的给药并未增加 AKI 的风险。晶体液给予过于限制与 AKI 风险增加相关,尤其是在老年患者、接受降压药物治疗的患者和手术时间延长的患者中。由于 AKI 与住院时间延长和术后发病率增加有关,因此在解决围手术期液体管理问题时,应考虑这些观察结果以改善预后。
不适用。